STAT

Novartis’ tone-deaf response to Michael Cohen: troubling, but not surprising

Novartis' contract with Michael Cohen, President Trump's lawyer, isn't its first questionable deal.
Source: Photo illustration: Dom Smith/STAT; Photo: Mark Wilson/Getty Images

When Donald Trump’s lawyer, Michael Cohen, approached Novartis early last year to provide access to the new Trump administration, the company’s response was tone-deaf. But it was hardly a surprise.

The personal lawyer and “fixer” for the president came knocking as big drug makers were anxious about the future, since candidate Trump had for through-the-roof prices. So former Novartis chief executive Joe Jimenez quickly authorized a one-year, . This was considerably more than Novartis Washington lobbyists. And it wasn’t for Cohen’s policy expertise — he knew nothing about health care.

You're reading a preview, sign up to read more.

More from STAT

STAT6 min readSociety
‘Maisie’s Army’: How A Grassroots Group Is Mobilizing To Help Toddlers Access A Lifesaving Drug
A grassroots group called "Maisie's Army" is mobilizing to help toddlers with a rare disease access a lifesaving drug.
STAT5 min readScience
A Writer Shared Her Story About Getting Frightening Genetic Results Online. The Response Was Surprising
A writer shared her story about getting frightening genetic results online. The response was surprising.
STAT7 min readTech
One Health Care Startup At A Time, This Venture Capitalist Wants To Harness The Investing Power Of Women
“If women want specific companies in the world that address their needs, the only way to do that is for women to become the investors."